Market News (Page 6) - TendieTensor

Market News Page 6 of 178 • 4,442 articles

Data Visualization Market - Forecasts from 2025 to 2030: Growth Propelled by the Exponential Increase in Data Generation, Necessitating Advanced Visualization Techniques

GlobeNewswire Inc. • Researchandmarkets.Com

Data Visualization Market - Forecasts from 2025 to 2030: Growth Propelled by the Exponential Increase in Data Generation, Necessitating Advanced Visualization Techniques

12/05/2025 05:58 AM • The data visualization market is projected to grow from $12.7 billion in 2025 to $21.4 billion by 2030, driven by increasing data generation and digital transformation across industries, with significant opportunities in cloud-based solutions and emerging markets.

JPM - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
CRM - Mentioned as a key player in a growing market with significant expansion potential

#data visualization #market growth #business intelligence #digital transformation #cloud solutions

Robotic Radiotherapy Market Size to Reach USD 3.18 Billion by 2032; Surging Development in Technology Augment Market Expansion Globally – SNS Insider

GlobeNewswire Inc. • Sns Insider

Robotic Radiotherapy Market Size to Reach USD 3.18 Billion by 2032; Surging Development in Technology Augment Market Expansion Globally – SNS Insider

12/05/2025 05:44 AM • The global Robotic Radiotherapy Market is expected to grow from USD 1.15 Billion in 2023 to USD 3.18 Billion by 2032, driven by technological advancements in cancer treatment and increasing precision in radiotherapy systems.

JPMpC - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
ARAY - Highlighted for advanced technology like CyberKnife System, which is being adopted by cancer treatment centers

#radiotherapy #cancer treatment #robotic technology #medical innovation #oncology

$1.22 Bn Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035: Growth Driven by Shift From Broad-Spectrum Treatments to Personalized Therapeutic Development

GlobeNewswire Inc. • Researchandmarkets.Com

$1.22 Bn Cell Therapy Packaging Market Industry Trends and Global Forecasts to 2035: Growth Driven by Shift From Broad-Spectrum Treatments to Personalized Therapeutic Development

12/05/2025 05:43 AM • The global cell therapy packaging market is projected to grow from $404 million in 2025 to $1.22 billion by 2035, driven by personalized cell therapies and technological innovations in packaging solutions.

JPMpD - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
TMO - Well-positioned in a market experiencing significant technological innovation and growth

#cell therapy #packaging market #personalized therapeutics #cryogenic storage #AI automation

Palantir Picks Northslope As First Elite AI Partner In Big Expansion Push

Benzinga • Lekha Gupta

Palantir Picks Northslope As First Elite AI Partner In Big Expansion Push

12/05/2025 05:42 AM • Palantir Technologies announced an expanded collaboration with Northslope, making them the first member of their Palantir Vanguard: Elite network. The partnership focuses on delivering transformative AI outcomes with enterprise-grade security.

JPMpJ - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
PLTR - Expanding AI partnerships, introducing new operating system, and showing strategic growth in AI infrastructure

#AI #partnership #enterprise #infrastructure

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

GlobeNewswire Inc. • Researchandmarkets.Com

CAR T-Cell Therapy Market Industry Trends and Global Forecasts to 2035 by Target Antigens, Target Indication, Key Geographies, Sales Forecast of Drugs and Leading Players

12/05/2025 05:41 AM • The global CAR T-cell therapy market is projected to grow from $4.6 billion in 2025 to $15.2 billion by 2035, with a 11.4% CAGR. The market is driven by technological advancements, personalized cancer treatment demand, and increased clinical trials, with a focus on CD19-targeting therapies.

JPMpK - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
NVS - Mentioned as a key player in CAR T-cell therapy market with successful therapies like Kymriah

#CAR T-cell therapy #cancer treatment #immunotherapy #clinical trials #personalized medicine

Small-Cap Reawakening May Push These 7%-14% Dividend Stocks Higher

Investing.com • Brett Owens

Small-Cap Reawakening May Push These 7%-14% Dividend Stocks Higher

12/05/2025 05:40 AM • The article discusses the potential resurgence of small-cap stocks, highlighting four dividend-paying companies in the business development and mortgage lending sectors that could benefit from potential Federal Reserve rate cuts.

JPMpL - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
NCDL - Young BDC with a high 13% dividend yield, but trading at an 18% discount to net asset value with potential uncertainty about long-term investor interest

#small-cap stocks #dividend stocks #Federal Reserve #rate cuts #mortgage lending #business development companies

Cloudflare Stock Dips in Premarket After Second Major Outage in as Many Weeks

Investing.com • Timothy Fries

Cloudflare Stock Dips in Premarket After Second Major Outage in as Many Weeks

12/05/2025 05:36 AM • Cloudflare experienced two major network outages in late 2025, impacting global internet services and causing its stock to dip in premarket trading. The first outage on November 18 was due to a database permissions error, while the second on December 5 affected major platforms like X and Canva.

JPMpM - Mentioned as one of top 5 accounts increasing advertising spend with Lamar Advertising
NET - Two significant network outages within weeks, causing widespread service disruptions and negatively impacting stock performance, with premarket trading showing a decline from previous closing price

#network outage #technical disruption #stock performance #internet services

GlobeNewswire Inc. • Clare Gamble-Dale

Form 8.5 (EPT/RI) - Greencore Group Plc

12/05/2025 05:00 AM • Shore Capital Stockbrokers Ltd disclosed trading activities for Greencore Group Plc, reporting purchases of 39,984 ordinary shares at 246.5p and sales of 34,985 shares at 247p on December 4, 2025.

GNCGY - The disclosure shows balanced trading activity with minimal price variation, indicating no strong market directional signal

#trading disclosure #stock transaction #takeover code

ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting

GlobeNewswire Inc. • Imcheck Therapeutics

ImCheck Announces Oral Presentation of ICT01 First-Line AML Data at the 67th ASH Annual Meeting

12/05/2025 05:00 AM • ImCheck Therapeutics presented promising clinical trial results for ICT01, a γ9δ2 T-cell activator, showing high remission rates and overall survival in older or unfit patients with newly diagnosed acute myeloid leukemia (AML) when combined with azacitidine and venetoclax.

IPSEY - Mentioned in context of a pending acquisition of ImCheck, with no specific performance details provided

#AML #immunotherapy #clinical trials #T-cell activation #cancer treatment

Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares

GlobeNewswire Inc. • Dimensional Fund Advisors Ltd.

Dimensional Fund Advisors Ltd. : Form 8.3 - BAKKAVOR GROUP PLC - Ordinary Shares

12/05/2025 03:42 AM • Dimensional Fund Advisors Ltd. disclosed a 1.11% ownership stake in Bakkavor Group PLC and made a sale of 8,569 shares at 2.3326 GBP per share, while also noting interests in Greencore Group PLC.

GNCGY - Mentioned in disclosure without specific trading details or market commentary

#Form 8.3 #Takeover Code #Position Disclosure #Stock Trading

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

GlobeNewswire Inc. • Dimensional Fund Advisors Ltd.

Dimensional Fund Advisors Ltd. : Form 8.3 - AMERICAN AXLE & MFG HOLDINGS - Ordinary Shares

12/05/2025 03:38 AM • Dimensional Fund Advisors disclosed a 5.61% ownership stake in American Axle & Manufacturing Holdings Inc and Dowlais Group PLC, reporting a purchase of 1,300 shares at $6.4950 per share.

AXL - Standard disclosure of stock ownership without indicating strong positive or negative market sentiment

#Form 8.3 #Takeover Code #Position Disclosure #Stock Ownership

Ensurge Micropower ASA – Commencement of subscription period in the Subsequent Offering

GlobeNewswire Inc. • Ensurge Micropower Asa

Ensurge Micropower ASA – Commencement of subscription period in the Subsequent Offering

12/05/2025 02:00 AM • Ensurge Micropower announced a subsequent offering of up to 22,222,222 new shares at NOK 0.90 per share, following a previous private placement. The subscription period runs from 5 December to 12 December 2025, with allocation rights for eligible shareholders.

EPRpC - Continuing growth trajectory, supported by ongoing development in oil waste and polluted water treatment
ENMPY - The company is conducting a standard follow-on share offering, which indicates ongoing financial activities without strong positive or negative implications. The offering suggests the company is seeking additional capital for potential growth or operational needs.

#subsequent offering #share issuance #microbattery technology #stock offering

NBPE Announces Transaction in Own Shares

GlobeNewswire Inc. • Nb Private Equity Partners

NBPE Announces Transaction in Own Shares

12/05/2025 02:00 AM • NB Private Equity Partners bought back 30,000 Class A Shares on the London Stock Exchange at prices between £15.50 and £15.58, which will be cancelled, reducing outstanding shares to 43,675,634.

NBGX - Mentioned as the parent company of NBPE's investment manager, with no specific market-moving information provided

#share buyback #London Stock Exchange #private equity #Class A Shares

US Layoffs Fall Sharply In November — So Why Are Companies Still Avoiding Hiring?

Benzinga • Eva Mathew

US Layoffs Fall Sharply In November — So Why Are Companies Still Avoiding Hiring?

12/05/2025 01:52 AM • US employers announced fewer layoffs in November 2025, with cuts falling 53% from October, but hiring remains weak. Companies are cautious about expanding workforce due to economic uncertainty, restructuring needs, and AI's impact on staffing.

EPRpE - Continuing growth trajectory, supported by ongoing development in oil waste and polluted water treatment
VZ - Led telecom sector layoffs in November, indicating potential organizational restructuring and cost-cutting measures

#layoffs #hiring #economic uncertainty #workforce #AI #technology sector

Why AI Stock Veritone Was Soaring This Week

The Motley Fool • Eric Volkman

Why AI Stock Veritone Was Soaring This Week

12/05/2025 01:34 AM • Veritone, an AI solutions provider, saw its stock rise nearly 26% after announcing a strategic partnership with edge computing company Armada to deliver integrated data solutions, and receiving a bullish analyst rating.

EPRpG - Continuing growth trajectory, supported by ongoing development in oil waste and polluted water treatment
VERI - Stock rose 26% due to new strategic partnership with Armada, potential for innovative data solutions, and a positive analyst rating with a $10 price target

#AI #edge computing #data fabric #strategic partnership #stock performance

Ipsen apporte des précisions sur l'héritage d'Henri Beaufour

GlobeNewswire Inc. • Ipsen

Ipsen apporte des précisions sur l'héritage d'Henri Beaufour

12/05/2025 12:58 AM • Ipsen reports that Beech Tree shares will be transferred to the Alasol Foundation following the death of Henri Beaufour, a board member and founding family representative. The transfer is expected in early 2026 after obtaining necessary regulatory approvals.

IPSEY - Reporting a planned share transfer following a board member's death, with no significant positive or negative business impact

#share transfer #foundation #board member #succession

Ipsen provides update on legacy of Henri Beaufour

GlobeNewswire Inc. • Ipsen

Ipsen provides update on legacy of Henri Beaufour

12/05/2025 12:58 AM • Ipsen announced that shares of Beech Tree will be transferred to the Alasol Foundation following the death of Board Member Henri Beaufour in November 2025. The transfer is expected to occur in early 2026 after obtaining regulatory approvals.

VEEV - Mentioned as a top holding with no specific performance details in the article
IPSEY - Reporting a routine corporate action following a board member's death, with no significant positive or negative implications

#share transfer #foundation #board member #regulatory approval

The Trade Desk: After a 70% Plunge, This Could Be the Time to Buy

Investing.com • Sam Quirke

The Trade Desk: After a 70% Plunge, This Could Be the Time to Buy

12/04/2025 10:45 PM • The Trade Desk stock has fallen 70% in 2025, but strong fundamentals, low valuation, and technical indicators suggest it might be an attractive investment opportunity for patient investors.

TTD - Despite 70% stock price drop, the company maintains strong operational performance with high-teens YoY revenue growth, 95%+ customer retention, positive earnings beat, and management confidence shown through share buyback program

#ad-tech #digital advertising #stock valuation #market sentiment

3 Signs Tesla Is Starting December on the Front Foot

Investing.com • Sam Quirke

3 Signs Tesla Is Starting December on the Front Foot

12/04/2025 10:42 PM • Tesla shows signs of recovery in December with technical strength, positive analyst sentiment, and improving operational performance, particularly in China's EV market, despite challenges in European sales.

DDOG - Mentioned as a top holding with no specific performance details in the article
TSLA - Stock rebounded from $385 to $430, technical indicators showing bullish signals, positive analyst ratings with price targets of $475-$508, strong performance in China with 10% year-over-year shipment growth, and plans to expand robotaxi fleet

#Tesla #EV market #stock performance #robotaxi #China sales

GlobeNewswire Inc. • Oric Pharmaceuticals

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and Previously Treated NSCLC Patients with EGFR Atypical Mutations at the ESMO Asia Congress 2025

12/04/2025 09:45 PM • ORIC Pharmaceuticals presented promising Phase 1b trial results for enozertinib, a potential treatment for non-small cell lung cancer (NSCLC) with EGFR mutations, showing strong systemic and CNS activity with favorable safety profile.

ORIC - Demonstrated strong preliminary results with 80% overall response rate in first-line NSCLC patients, 100% intracranial response rate, and no significant off-target toxicities, indicating promising drug development progress

#enozertinib #NSCLC #EGFR mutations #clinical trial #cancer treatment

CEA Industries (Nasdaq: BNC) Responds to YZi Labs, Re-Affirms Commitment to BNB DAT Strategy, and Welcomes Shareholder Engagement

GlobeNewswire Inc. • Cea Industries

CEA Industries (Nasdaq: BNC) Responds to YZi Labs, Re-Affirms Commitment to BNB DAT Strategy, and Welcomes Shareholder Engagement

12/04/2025 07:56 PM • CEA Industries reaffirms its commitment to BNB digital asset treasury strategy, responding to YZi Labs' recent shareholder communication and proposed board reconstitution. The company emphasizes its continued focus on maintaining the world's largest BNB token treasury.

LLY - Record upside surprise in earnings per share and revenue, potential to break previous stock price highs
BNC - Company confidently addresses shareholder concerns, highlights recent board appointments, and demonstrates commitment to its digital asset strategy

#BNB #digital asset treasury #shareholder engagement #board of directors

Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA

GlobeNewswire Inc. • Ascentage Pharma

Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Treatment of Ph+ ALL Cleared by US FDA and EMA

12/04/2025 07:00 PM • Ascentage Pharma received FDA and EMA clearance to conduct a global Phase III study of olverembatinib for treating newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), with promising early data showing high minimal residual disease negativity rates.

MSFT - Disappointed investors with recent quarterly results
AAPG - Company advancing promising cancer treatment with global regulatory approvals and potential breakthrough therapy for Ph+ ALL

#olverembatinib #Ph+ ALL #clinical trial #FDA #EMA #tyrosine kinase inhibitor

FormFactor Announces Participation in 14th Annual NYC Summit

GlobeNewswire Inc. • Formfactor, Inc.

FormFactor Announces Participation in 14th Annual NYC Summit

12/04/2025 07:00 PM • FormFactor will join 14 other technology companies at the 14th Annual NYC Summit investor conference on December 16th, 2025, featuring small group meetings and networking opportunities for investors and analysts.

AMZN - Surpassed earnings expectations, reached new record highs above $250 per share, steady profit growth since 2022
FORM - Company is actively participating in a prominent investor conference, showcasing engagement with investors and industry peers

#investor conference #technology #semiconductor #networking

First Nordic Provides Update on Arrangement with Mawson Finland and Announces Consolidation

Benzinga • Prnewswire

First Nordic Provides Update on Arrangement with Mawson Finland and Announces Consolidation

12/04/2025 06:31 PM • First Nordic Metals Corp announced the approval of its acquisition of Mawson Finland Limited through a statutory plan of arrangement, targeting closing on December 16, 2025. The company will also consolidate its common shares at a 4:1 ratio, effective December 10, 2025.

META - Shares dropped more than 15% in past week after latest earnings report
AEM - Mentioned as a joint venture partner for the Barsele gold project, with no significant positive or negative implications in this article

#acquisition #consolidation #share restructuring #metals exploration

authID Selected to Biometrically Secure Identities for Online Educational Services at Correctional Facilities

GlobeNewswire Inc. • Rhon Daguro

authID Selected to Biometrically Secure Identities for Online Educational Services at Correctional Facilities

12/04/2025 05:59 PM • authID has been selected by an east coast technology organization serving the criminal justice sector to provide biometric identity authentication for administrators, staff, and incarcerated individuals in educational services, replacing their existing homegrown solution.

AUID - Company secured a new contract, demonstrated superior technology capabilities, and expanded into the distance learning market with a solution that addresses security, privacy, and authentication challenges

#biometric authentication #correctional facilities #identity verification #online education #privacy protection